The AstraZeneca PLC ADR AZN,
fell 1.41% to $ 50.19 on Thursday, which was an excellent trading session for the stock market, with the NASDAQ Composite Index COMP,
with 2.56% to 13,067.48 and the Dow Jones Industrial Average DJIA,
by 0.69% to 31,041.13. The fall of the ADR dropped a three-day winning streak. AstraZeneca PLC ADR closed $ 14.75 as the 52-week high ($ 64.94) the company reached on July 20th.
The ADR underperformed compared to some of its competitors on Thursday as AbbVie Inc. ABBV,
rose 1.07% to $ 106.71, Amgen Inc. AMGN,
rose 0.33% to $ 234.02, and Gilead Sciences Inc. VALID,
rose 0.92% to $ 62.52. The trading volume (13.6 million) obscured its 50-day average volume of 10.2 million.
Editor’s Note: This story was automatically generated by Automated Insights using Dow Jones and FactSet data. See our Terms of Use for Market Data.